A detailed history of Quarry LP transactions in Repligen Corp stock. As of the latest transaction made, Quarry LP holds 269 shares of RGEN stock, worth $42,539. This represents 0.01% of its overall portfolio holdings.

Number of Shares
269
Previous 30 796.67%
Holding current value
$42,539
Previous $3.78 Million 958.51%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $28,629 - $39,996
239 Added 796.67%
269 $40 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $3,600 - $5,488
30 New
30 $3.78 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.78B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.